Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Allison Braunwald Goldfine, M.D.

TitleAssociate Professor of Medicine
InstitutionJoslin Diabetes Center
DepartmentMedicine
AddressJoslin Diabetes Center
Cellular/Molecular Physiology
One Joslin Place
Boston MA 02215
Phone617/732-2643
Fax617/713-3403

 Mentoring 
 completed student projects
Altered Bile Acid Composition in Post Roux-en Y Bariatric Patients
Summer, 06/12/06 - 08/11/06

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Goldfine AB, Vernon A, Zinner M. Where are the health care cost savings with bariatric surgery in obesity management? JAMA Surg. 2014 Jan 1; 149(1):5-6.
    View in: PubMed
  2. Phua EJ, Lopez X, Ramus J, Goldfine AB. Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use. Diabetes Care. 2013 Dec; 36(12):e204-5.
    View in: PubMed
  3. Goldfine AB, Patti ME. Diabetes: Bariatric surgery for T2DM-cure, or remission and relapse? Nat Rev Endocrinol. 2014 Jan; 10(1):8-9.
    View in: PubMed
  4. Willsky GR, Halvorsen K, Godzala Iii ME, Chi LH, Most MJ, Kaszynski P, Crans DC, Goldfine AB, Kostyniak PJ. Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients. Metallomics. 2013 Oct 23; 5(11):1491-502.
    View in: PubMed
  5. Goldfine AB, Buck JS, Desouza C, Fonseca V, Chen YD, Shoelson SE, Jablonski KA, Creager MA. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care. 2013 Dec; 36(12):4132-9.
    View in: PubMed
  6. Goldfine AB, Fonseca V, Jablonski KA, Chen YD, Tipton L, Staten MA, Shoelson SE. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann Intern Med. 2013 Jul 2; 159(1):1-12.
    View in: PubMed
  7. Ghosh P, Sahoo R, Vaidya A, Cantel S, Kavishwar A, Goldfine A, Herring N, Bry L, Chorev M, Halperin JA. A specific and sensitive assay for blood levels of glycated CD59: A novel biomarker for diabetes. Am J Hematol. 2013 Aug; 88(8):670-6.
    View in: PubMed
  8. Shah RV, Goldfine AB. Response to letter regarding article, ''Statins and risk of new-onset diabetes mellitus''. Circulation. 2013 Jun 11; 127(23):e838.
    View in: PubMed
  9. Halperin F, Goldfine AB. Metabolic surgery for type 2 diabetes: efficacy and risks. Curr Opin Endocrinol Diabetes Obes. 2013 Apr; 20(2):98-105.
    View in: PubMed
  10. Goldfine AB, Conlin PR, Halperin F, Koska J, Permana P, Schwenke D, Shoelson SE, Reaven PD. A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia. 2013 Apr; 56(4):714-23.
    View in: PubMed
  11. Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer PE. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes. J Pediatr Endocrinol Metab. 2013; 26(9-10):995-8.
    View in: PubMed
  12. Mehta SN, Goldfine AB, Abrahamson MJ, Divincenzo R, Laffel LM. Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation. J Diabetes Sci Technol. 2013; 7(1):119-22.
    View in: PubMed
  13. Shah RV, Goldfine AB. Statins and risk of new-onset diabetes mellitus. Circulation. 2012 Oct 30; 126(18):e282-4.
    View in: PubMed
  14. Goldfine AB, Kulkarni RN. Modulation of ß-cell function: a translational journey from the bench to the bedside. Diabetes Obes Metab. 2012 Oct; 14 Suppl 3:152-60.
    View in: PubMed
  15. Hiatt WR, Goldfine AB, Kaul S. Cardiovascular risk assessment in the development of new drugs for obesity. JAMA. 2012 Sep 19; 308(11):1099-100.
    View in: PubMed
  16. Goldfine AB. Statins: is it really time to reassess benefits and risks? N Engl J Med. 2012 May 10; 366(19):1752-5.
    View in: PubMed
  17. Hiatt WR, Thomas A, Goldfine AB. What cost weight loss? Circulation. 2012 Mar 6; 125(9):1171-7.
    View in: PubMed
  18. Halperin F, Lopez X, Manning R, Kahn CR, Kulkarni RN, Goldfine AB. Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Diabetes. 2012 Feb; 61(2):301-9.
    View in: PubMed
  19. Saxena AR, Seely EW, Goldfine AB. Cardiovascular risk factors and menstrual cycle phase in pre-menopausal women. J Endocrinol Invest. 2012 Sep; 35(8):715-9.
    View in: PubMed
  20. Lopez X, Cypess A, Manning R, O'Shea S, Kulkarni RN, Goldfine AB. Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids. J Clin Endocrinol Metab. 2011 Dec; 96(12):3811-21.
    View in: PubMed
  21. Goldfine AB, Kaul S, Hiatt WR. Fibrates in the treatment of dyslipidemias--time for a reassessment. N Engl J Med. 2011 Aug 11; 365(6):481-4.
    View in: PubMed
  22. Pihlajamäki J, Lerin C, Itkonen P, Boes T, Floss T, Schroeder J, Dearie F, Crunkhorn S, Burak F, Jimenez-Chillaron JC, Kuulasmaa T, Miettinen P, Park PJ, Nasser I, Zhao Z, Zhang Z, Xu Y, Wurst W, Ren H, Morris AJ, Stamm S, Goldfine AB, Laakso M, Patti ME. Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. Cell Metab. 2011 Aug 3; 14(2):208-18.
    View in: PubMed
  23. Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, Smith RJ, Smith SR. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab. 2011 Jun; 96(6):1654-63.
    View in: PubMed
  24. Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, Smith RJ, Smith SR. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care. 2011 Jun; 34(6):1424-30.
    View in: PubMed
  25. Bezy O, Tran TT, Pihlajamäki J, Suzuki R, Emanuelli B, Winnay J, Mori MA, Haas J, Biddinger SB, Leitges M, Goldfine AB, Patti ME, King GL, Kahn CR. PKCd regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest. 2011 Jun; 121(6):2504-17.
    View in: PubMed
  26. Drucker DJ, Goldfine AB. Cardiovascular safety and diabetes drug development. Lancet. 2011 Mar 19; 377(9770):977-9.
    View in: PubMed
  27. Jin W, Goldfine AB, Boes T, Henry RR, Ciaraldi TP, Kim EY, Emecan M, Fitzpatrick C, Sen A, Shah A, Mun E, Vokes V, Schroeder J, Tatro E, Jimenez-Chillaron J, Patti ME. Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J Clin Invest. 2011 Mar; 121(3):918-29.
    View in: PubMed
  28. Lautz D, Halperin F, Goebel-Fabbri A, Goldfine AB. The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care. 2011 Mar; 34(3):763-70.
    View in: PubMed
  29. Halperin F, Patti ME, Skow M, Bajwa M, Goldfine AB. Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes. 2011; 2011:869536.
    View in: PubMed
  30. Sacks DB, Fonseca V, Goldfine AB. Diabetes: advances and controversies. Clin Chem. 2011 Feb; 57(2):147-9.
    View in: PubMed
  31. Goldfine AB, Gerwien RW, Kolberg JA, O'Shea S, Hamren S, Hein GP, Xu XM, Patti ME. Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion. Clin Chem. 2011 Feb; 57(2):326-37.
    View in: PubMed
  32. Goldfine AB, Fonseca V, Shoelson SE. Therapeutic approaches to target inflammation in type 2 diabetes. Clin Chem. 2011 Feb; 57(2):162-7.
    View in: PubMed
  33. Reubi JC, Perren A, Rehmann R, Waser B, Christ E, Callery M, Goldfine AB, Patti ME. Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass. Diabetologia. 2010 Dec; 53(12):2641-5.
    View in: PubMed
  34. Patti ME, Goldfine AB. Hypoglycaemia following gastric bypass surgery--diabetes remission in the extreme? Diabetologia. 2010 Nov; 53(11):2276-9.
    View in: PubMed
  35. Christen T, Sheikine Y, Rocha VZ, Hurwitz S, Goldfine AB, Di Carli M, Libby P. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. JACC Cardiovasc Imaging. 2010 Aug; 3(8):843-51.
    View in: PubMed
  36. Pearson JF, Bachireddy C, Shyamprasad S, Goldfine AB, Brownstein JS. Association between fine particulate matter and diabetes prevalence in the U.S. Diabetes Care. 2010 Oct; 33(10):2196-201.
    View in: PubMed
  37. Fonseca VA, Zinman B, Nauck MA, Goldfine AB, Plutzky J. Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies. Am J Med. 2010 Jul; 123(7):S2-S10.
    View in: PubMed
  38. Kennedy J, Katsuta H, Jung MH, Marselli L, Goldfine AB, Balis UJ, Sgroi D, Bonner-Weir S, Weir GC. Protective unfolded protein response in human pancreatic beta cells transplanted into mice. PLoS One. 2010; 5(6):e11211.
    View in: PubMed
  39. Goldfine AB, Fonseca V. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2010 Jun 8; 121(22):2447-9.
    View in: PubMed
  40. Beckman JA, Goldfine AB, Goldin A, Prsic A, Kim S, Creager MA. Inhibition of protein kinase Cbeta does not improve endothelial function in type 2 diabetes. J Clin Endocrinol Metab. 2010 Aug; 95(8):3783-7.
    View in: PubMed
  41. Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes. 2010 Apr; 17(2):113-9.
    View in: PubMed
  42. Chisholm JW, Goldfine AB, Dhalla AK, Braunwald E, Morrow DA, Karwatowska-Prokopczuk E, Belardinelli L. Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome. Diabetes Care. 2010 Jun; 33(6):1163-8.
    View in: PubMed
  43. Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med. 2010 Mar 16; 152(6):346-57.
    View in: PubMed
  44. Bouche C, Lopez X, Fleischman A, Cypess AM, O'Shea S, Stefanovski D, Bergman RN, Rogatsky E, Stein DT, Kahn CR, Kulkarni RN, Goldfine AB. Insulin enhances glucose-stimulated insulin secretion in healthy humans. Proc Natl Acad Sci U S A. 2010 Mar 9; 107(10):4770-5.
    View in: PubMed
  45. Halperin F, Patti ME, Goldfine AB. Glucagon treatment for post-gastric bypass hypoglycemia. Obesity (Silver Spring). 2010 Sep; 18(9):1858-60.
    View in: PubMed
  46. Brownstein JS, Murphy SN, Goldfine AB, Grant RW, Sordo M, Gainer V, Colecchi JA, Dubey A, Nathan DM, Glaser JP, Kohane IS. Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care. 2010 Mar; 33(3):526-31.
    View in: PubMed
  47. Goldfine AB, Fonseca VA, Jones MR, Wang AC, Ford DM, Truitt KE. Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes. Horm Metab Res. 2010 Jan; 42(1):23-30.
    View in: PubMed
  48. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009 Aug; 15(8):930-9.
    View in: PubMed
  49. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, Ridker PM, Van Dyke TE, Roberts WC. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009 Jul; 80(7):1021-32.
    View in: PubMed
  50. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, Ridker PM, Van Dyke TE, Roberts WC. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol. 2009 Jul 1; 104(1):59-68.
    View in: PubMed
  51. Pihlajamäki J, Boes T, Kim EY, Dearie F, Kim BW, Schroeder J, Mun E, Nasser I, Park PJ, Bianco AC, Goldfine AB, Patti ME. Thyroid hormone-related regulation of gene expression in human fatty liver. J Clin Endocrinol Metab. 2009 Sep; 94(9):3521-9.
    View in: PubMed
  52. Goldfine AB, Shoelson SE, Aguirre V. Expansion and contraction: treating diabetes with bariatric surgery. Nat Med. 2009 Jun; 15(6):616-7.
    View in: PubMed
  53. Goldfine AB, Fonseca VA. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects. Postgrad Med. 2009 May; 121(3 Suppl 1):13-8.
    View in: PubMed
  54. Wang XL, Suzuki R, Lee K, Tran T, Gunton JE, Saha AK, Patti ME, Goldfine A, Ruderman NB, Gonzalez FJ, Kahn CR. Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones. Cell Metab. 2009 May; 9(5):428-39.
    View in: PubMed
  55. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009 Apr 9; 360(15):1509-17.
    View in: PubMed
  56. Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, Badman MK, Maratos-Flier E, Mun EC, Pihlajamaki J, Auwerx J, Goldfine AB. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 2009 Sep; 17(9):1671-7.
    View in: PubMed
  57. Frachetti KJ, Goldfine AB. Bariatric surgery for diabetes management. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):119-24.
    View in: PubMed
  58. Shoelson SE, Goldfine AB. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat Med. 2009 Apr; 15(4):373-4.
    View in: PubMed
  59. Goldfine AB. Assessing the cardiovascular safety of diabetes therapies. N Engl J Med. 2008 Sep 11; 359(11):1092-5.
    View in: PubMed
  60. Goldfine AB. Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway. Curr Opin Cardiol. 2008 Sep; 23(5):502-11.
    View in: PubMed
  61. Lopez X, Bouché C, Tatro E, Goldfine AB. Family history of diabetes impacts on interactions between minimal model estimates of insulin sensitivity and glucose effectiveness. Diabetes Obes Metab. 2009 Feb; 11(2):123-30.
    View in: PubMed
  62. Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, Lee J, Shoelson SE. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci. 2008 May; 1(1):36-43.
    View in: PubMed
  63. Goldfine AB, Beckman JA. Life and death in Denmark: lessons about diabetes and coronary heart disease. Circulation. 2008 Apr 15; 117(15):1914-7.
    View in: PubMed
  64. Goldfine AB. The rough road for rosiglitazone. Curr Opin Endocrinol Diabetes Obes. 2008 Apr; 15(2):113-7.
    View in: PubMed
  65. Lopez X, Castells M, Ricker A, Velazquez EF, Mun E, Goldfine AB. Human insulin analog--induced lipoatrophy. Diabetes Care. 2008 Mar; 31(3):442-4.
    View in: PubMed
  66. Fleischman A, Shoelson SE, Bernier R, Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care. 2008 Feb; 31(2):289-94.
    View in: PubMed
  67. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ, Patti ME. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007 Dec; 92(12):4678-85.
    View in: PubMed
  68. Bentley-Lewis R, Goldfine AB, Green DE, Seely EW. Lactation after normal pregnancy is not associated with blood glucose fluctuations. Diabetes Care. 2007 Nov; 30(11):2792-3.
    View in: PubMed
  69. Goldfine AB. Changing horizons: approaches to diabetes care, current and future. Curr Opin Endocrinol Diabetes Obes. 2007 Apr; 14(2):95-7.
    View in: PubMed
  70. Beckman JA, Goldfine AB, Dunaif A, Gerhard-Herman M, Creager MA. Endothelial function varies according to insulin resistance disease type. Diabetes Care. 2007 May; 30(5):1226-32.
    View in: PubMed
  71. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006 Jul; 116(7):1793-801.
    View in: PubMed
  72. Goldfine AB, Beckman JA, Betensky RA, Devlin H, Hurley S, Varo N, Schonbeck U, Patti ME, Creager MA. Family history of diabetes is a major determinant of endothelial function. J Am Coll Cardiol. 2006 Jun 20; 47(12):2456-61.
    View in: PubMed
  73. Bohlhalter S, Goldfine A, Matteson S, Garraux G, Hanakawa T, Kansaku K, Wurzman R, Hallett M. Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain. 2006 Aug; 129(Pt 8):2029-37.
    View in: PubMed
  74. Goldfine AB, Crunkhorn S, Costello M, Gami H, Landaker EJ, Niinobe M, Yoshikawa K, Lo D, Warren A, Jimenez-Chillaron J, Patti ME. Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue. Diabetes. 2006 Mar; 55(3):640-50.
    View in: PubMed
  75. Naruse K, Rask-Madsen C, Takahara N, Ha SW, Suzuma K, Way KJ, Jacobs JR, Clermont AC, Ueki K, Ohshiro Y, Zhang J, Goldfine AB, King GL. Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes. 2006 Mar; 55(3):691-8.
    View in: PubMed
  76. Chan JL, Mun EC, Stoyneva V, Mantzoros CS, Goldfine AB. Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring). 2006 Feb; 14(2):194-8.
    View in: PubMed
  77. Mehta SS, Silver RJ, Aaronson A, Abrahamson M, Goldfine AB. Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus. Am J Cardiol. 2006 Feb 15; 97(4):567-70.
    View in: PubMed
  78. Silver RJ, Mehta S, Soeldner JS, Martin BC, Warram JH, Goldfine AB. Acute insulin secretion as a predictor of weight gain in healthy humans. Obesity (Silver Spring). 2006 Jan; 14(1):67-72.
    View in: PubMed
  79. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia. 2005 Nov; 48(11):2236-40.
    View in: PubMed
  80. Halperin F, Beckman JA, Patti ME, Trujillo ME, Garvin M, Creager MA, Scherer PE, Goldfine AB. The role of total and high-molecular-weight complex of adiponectin in vascular function in offspring whose parents both had type 2 diabetes. Diabetologia. 2005 Oct; 48(10):2147-54.
    View in: PubMed
  81. Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA. 2004 Nov 24; 292(20):2482-90.
    View in: PubMed
  82. Bouché C, Serdy S, Kahn CR, Goldfine AB. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev. 2004 Oct; 25(5):807-30.
    View in: PubMed
  83. Qin X, Goldfine A, Krumrei N, Grubissich L, Acosta J, Chorev M, Hays AP, Halperin JA. Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes. 2004 Oct; 53(10):2653-61.
    View in: PubMed
  84. Aldhahi W, Armstrong J, Bouche C, Carr RD, Moses A, Goldfine AB. Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemia. J Clin Endocrinol Metab. 2004 Sep; 89(9):4553-7.
    View in: PubMed
  85. Aldhahi W, Mun E, Goldfine AB. Portal and peripheral cortisol levels in obese humans. Diabetologia. 2004 May; 47(5):833-6.
    View in: PubMed
  86. Goldfine AB, Kahn CR. Adiponectin: linking the fat cell to insulin sensitivity. Lancet. 2003 Nov 1; 362(9394):1431-2.
    View in: PubMed
  87. Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, Goldfine A. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res. 2003 Aug; 11(8):919-24.
    View in: PubMed
  88. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Keaney JF, Creager MA. Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2003 Dec; 285(6):H2392-8.
    View in: PubMed
  89. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003 Jul 8; 100(14):8466-71.
    View in: PubMed
  90. Varo N, Vicent D, Libby P, Nuzzo R, Calle-Pascual AL, Bernal MR, Fernández-Cruz A, Veves A, Jarolim P, Varo JJ, Goldfine A, Horton E, Schönbeck U. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation. 2003 Jun 3; 107(21):2664-9.
    View in: PubMed
  91. Goldfine AB, Bouche C, Parker RA, Kim C, Kerivan A, Soeldner JS, Martin BC, Warram JH, Kahn CR. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A. 2003 Mar 4; 100(5):2724-9.
    View in: PubMed
  92. Bouche C, Goldfine AB. Prevention of type 2 diabetes: are we ready? Minerva Med. 2003 Feb; 94(1):9-18.
    View in: PubMed
  93. Goldfine AB, Goldfine HL. Cardiology patient pages. Cardiovascular disease in the diabetic patient. Circulation. 2003 Jan 21; 107(2):e14-6.
    View in: PubMed
  94. Goldfine AB, Ebbeling CB, Ludwig DS. Antegrade intravenous catheterization for metabolic studies in man. Diabetologia. 2002 Dec; 45(12):1742-3.
    View in: PubMed
  95. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res. 2002 Jan 11; 90(1):107-11.
    View in: PubMed
  96. Goldfine AB. Type 2 diabetes: new drugs, new perspectives. Hosp Pract (Minneap). 2001 Sep 15; 36(9):29-36.
    View in: PubMed
  97. Willsky GR, Goldfine AB, Kostyniak PJ, McNeill JH, Yang LQ, Khan HR, Crans DC. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV). J Inorg Biochem. 2001 May; 85(1):33-42.
    View in: PubMed
  98. Beckman JA, Goldfine AB, Gordon MB, Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation. 2001 Mar 27; 103(12):1618-23.
    View in: PubMed
  99. Acosta J, Hettinga J, Flückiger R, Krumrei N, Goldfine A, Angarita L, Halperin J. Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A. 2000 May 9; 97(10):5450-5.
    View in: PubMed
  100. Goldfine AB, Patti ME, Zuberi L, Goldstein BJ, LeBlanc R, Landaker EJ, Jiang ZY, Willsky GR, Kahn CR. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism. 2000 Mar; 49(3):400-10.
    View in: PubMed
  101. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998 May 5; 97(17):1695-701.
    View in: PubMed
  102. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR. In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol Cell Biochem. 1995 Dec 6-20; 153(1-2):217-31.
    View in: PubMed
  103. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab. 1995 Nov; 80(11):3311-20.
    View in: PubMed
  104. Magré J, Goldfine AB, Warram JH, Krolewski AS, Kahn CR. Analysis of the insulin receptor gene in noninsulin-dependent diabetes mellitus by denaturing gradient gel blots: a clinical research center study. J Clin Endocrinol Metab. 1995 Jun; 80(6):1882-7.
    View in: PubMed
  105. Goldfine AB, Kahn CR. Insulin allergy and insulin resistance. Curr Ther Endocrinol Metab. 1994; 5:461-4.
    View in: PubMed
  106. Kahn CR, Goldfine AB. Molecular determinants of insulin action. J Diabetes Complications. 1993 Apr-Jun; 7(2):92-105.
    View in: PubMed
  107. Kaye TB, Rubin RA, Goldfine AB, Rajamani K, Kinsley BT, Vischer UM, Simonson DC. Effect of glycemic control on the overnight dexamethasone suppression test in patients with diabetes mellitus. J Clin Endocrinol Metab. 1992 Mar; 74(3):640-4.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Goldfine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_